Skip to main content
. Author manuscript; available in PMC: 2016 May 12.
Published in final edited form as: Arthritis Care Res (Hoboken). 2016 May;68(5):689–694. doi: 10.1002/acr.22728

Figure 2.

Figure 2

Kaplan-Meier pulmonary outcome curves for interstitial lung disease patients with A, melanoma differentiation–associated gene 5 (MDA-5) positive versus MDA-5 negative, and B, clinically amyopathic dermatomyositis (CADM) versus classic dermatomyositis (DM). Anti–MDA-5 positivity was significantly associated with poor pulmonary outcome. CADM was not predictive of poor pulmonary outcome. NS=not significant.